ALANINE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ALANINE
Largest movements
- Cash -€5,248
down €5,248 (-16.1%), from €32,525 to €27,277
mainly Net result for the year (-€7,172) and Receivables within one year (-€578)
- Receivables within one year +€578
up €578 (+124%), from €466 to €1,044
of which Trade receivables: +€672
- Profit (loss) carried forward -€7,172
down €7,172 (-0.4%), from -€1.7m to -€1.7m
- Trade debts +€2,498
up €2,498 (+784%), from €318 to €2,816
- Gross operating margin -€2,106
down €2,106 (-43.2%), from -€4,875 to -€6,981
- Other operating charges -€215
no longer reported in 2025 (was €215)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €32,992 | €28,321 | -€4,671 | -14.2% |
| Current assets | 29/58 | €32,992 | €28,321 | -€4,671 | -14.2% |
| Amounts receivable within one year | 40/41 | €466 | €1,044 | +€578 | +124% |
| Trade receivables | 40 | €197 | €870 | +€672 | +340% |
| Other amounts receivable | 41 | €269 | €174 | -€95 | -35.2% |
| Cash at bank and in hand | 54/58 | €32,525 | €27,277 | -€5,248 | -16.1% |
| Total equity and liabilities | 10/49 | €32,992 | €28,321 | -€4,671 | -14.2% |
| Equity | 10/15 | -€1,622,586 | -€1,629,759 | -€7,172 | -0.4% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Capital | 10 | €100,000 | €100,000 | = | 0.0% |
| Issued capital | 100 | €100,000 | €100,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€1,722,586 | -€1,729,759 | -€7,172 | -0.4% |
| Amounts payable | 17/49 | €1,655,578 | €1,658,080 | +€2,502 | +0.2% |
| Amounts payable within one year | 42/48 | €1,655,565 | €1,658,063 | +€2,498 | +0.2% |
| Trade debts | 44 | €318 | €2,816 | +€2,498 | +784% |
| Suppliers | 440/4 | €318 | €2,816 | +€2,498 | +784% |
| Other amounts payable | 47/48 | €1,655,246 | €1,655,246 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €13 | €17 | +€4 | +32.8% |
| Other operating charges | 640/8 | €215 | - | -€215 | |
| Gross operating margin | 9900 | -€4,875 | -€6,981 | -€2,106 | -43.2% |
| Operating profit (loss) | 9901 | -€5,090 | -€6,981 | -€1,891 | -37.1% |
| Financial income | 75/76B | €38 | - | -€38 | |
| Recurring financial income | 75 | €38 | - | -€38 | |
| Financial charges | 65/66B | €201 | €192 | -€9 | -4.6% |
| Recurring financial charges | 65 | €201 | €192 | -€9 | -4.6% |
| Profit (loss) for the period before taxes | 9903 | -€5,253 | -€7,172 | -€1,920 | -36.5% |
| Profit (loss) for the period | 9904 | -€5,253 | -€7,172 | -€1,920 | -36.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€5,253 | -€7,172 | -€1,920 | -36.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.